Pfizer Inc.
PFE
$25.06
-$0.73-2.83%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.54B | -- | 2.97B | 410.00M | 4.47B |
| Total Depreciation and Amortization | 1.66B | -- | 1.61B | 1.79B | 1.75B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -561.00M | -- | -327.00M | 1.60B | -377.00M |
| Change in Net Operating Assets | -36.00M | -- | -1.92B | 2.93B | 879.00M |
| Cash from Operations | 4.60B | -- | 2.34B | 6.72B | 6.71B |
| Capital Expenditure | -602.00M | -- | -564.00M | -917.00M | -651.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.83B | -- | 3.84B | -706.00M | -1.41B |
| Cash from Investing | -2.43B | -- | 3.27B | -1.62B | -2.06B |
| Total Debt Issued | 0.00 | -- | -- | 732.00M | 2.16B |
| Total Debt Repaid | 6.00M | -- | -2.43B | -3.45B | -4.41B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.44B | -- | -2.44B | -2.38B | -2.38B |
| Other Financing Activities | -39.00M | -- | -356.00M | -14.00M | -6.00M |
| Cash from Financing | -2.48B | -- | -5.23B | -5.11B | -4.64B |
| Foreign Exchange rate Adjustments | 2.00M | -- | -7.00M | -29.00M | 9.00M |
| Miscellaneous Cash Flow Adjustments | 2.00M | -- | -1.00M | -- | -1.00M |
| Net Change in Cash | -300.00M | -- | 374.00M | -45.00M | 29.00M |